ArticleOncogene2026

METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation.

Guanli Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.